login
login

Europe Daily Bulletin No. 7922

14 March 2001
Contents Publication in full By article 44 / 54
ECONOMIC INTERPENETRATION / (eu) pharmaceuticals

The American group ABBOTT LABORATORIES will acquire a significant stake in the capital of its fellow national MILLENIUM in order to jointly develop and market medicines against diabetes and obesity. It will initially acquire MILLENIUM shares for a value of USD 50 million then, for the equivalent of USD 200 million during the next two years.

Contents

A LOOK BEHIND THE NEWS
THE DAY IN POLITICS
GENERAL NEWS
ECONOMIC INTERPENETRATION